Although two randomised, placebo-controlled clinical trials of the type I anti-CD20 antibodies rituximab and ocrelizumab in patients with lupus nephritis failed to show a difference vs placebo in the ...
The antibody response to infection and vaccination is ... Shen and colleagues identify and characterize two distinct types of myeloid–B cell interaction that may signal solid tumour-induced ...
Oct. 9, 2024 — Researchers have developed a groundbreaking cell culture platform that enables the formation of two distinct but interconnected vascular networks. Their breakthrough holds ...
Oct. 11, 2024 — Researchers have developed a new method to recreate a robust and functional human immune system in mice using mononuclear cells from the cord blood. This new kind of mice ...
Hello and welcome to Virtual Investor Conferences. My name is Cecilia, and on behalf of OTC Markets, as well as our co-host Zacks Small Cap Research, we're very pleased you've joined us for our next ...